FDA approves Aspen’s drug to prevent preterm birthActive Pharmaceutical Ingredients, Antiretroviral Therapy, Approvals, FDA, FDA/Regulatory, Menopausal Hormone Therapy, Pregnancies, Preterm Births, Shares, Women’s HealthThe U.S. Food and Drug Administration approved South African drugmaker Aspen Pharmacare’s hydroxyprogesterone caproate (HPC), which is used to prevent preterm birth in pregnant women. Read more September 12, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-09-12 12:43:122019-09-12 13:34:34FDA approves Aspen’s drug to prevent preterm birth
